Cargando…
Metagenomic Next Generation Sequencing in the Detection of Pathogens in Cerebrospinal Fluid of Patients After Alternative Donor Transplantation: A Feasibility Analysis
Central nervous system (CNS) complications can occur in 9%–15% of patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The clinical manifestations of the CNS complications are non-specific, with most of them being disturbances of consciousness, convulsions, headaches, fever...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476959/ https://www.ncbi.nlm.nih.gov/pubmed/34595132 http://dx.doi.org/10.3389/fcimb.2021.720132 |
_version_ | 1784575736590368768 |
---|---|
author | Zhang, Binglei Zhou, Jian Gui, Ruirui Li, Zhen Zu, Yingling Wang, Juan Yu, Fengkuan Zhang, Yanli Zhao, Huifang Ji, Zhenyu Song, Yongping |
author_facet | Zhang, Binglei Zhou, Jian Gui, Ruirui Li, Zhen Zu, Yingling Wang, Juan Yu, Fengkuan Zhang, Yanli Zhao, Huifang Ji, Zhenyu Song, Yongping |
author_sort | Zhang, Binglei |
collection | PubMed |
description | Central nervous system (CNS) complications can occur in 9%–15% of patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The clinical manifestations of the CNS complications are non-specific, with most of them being disturbances of consciousness, convulsions, headaches, fever, and epilepsy, making it difficult to infer the cause of the complications based on clinical manifestations. We retrospectively analyzed the sensitivity and feasibility of metagenomic next generation sequencing (mNGS) in the diagnosis of CNS infections after allo-HSCT. Lumbar punctures were performed on 20 patients with CNS symptoms after receiving alternative donor HSCT(AD-HSCT) at the Affiliated Cancer Hospital of Zhengzhou University from February 2019 to December 2020, and their cerebrospinal fluid (CSF) was collected. The mNGS technique was used to detect pathogens in the CSF. Routine CSF testing, biochemical analyses, G experiments, GM experiments, ink staining, acid-fast staining, and bacterial cultures were carried out, and quantitative PCR (qPCR) tests were used to detect cytomegalovirus (CMV), Epstein-Barr virus (EBV), BK polyomavirus (BKPyV), and human alphaherpesvirus (HHV). A total of 29 tests were performed with 21 of them being positive. Of the five negative patients, three were diagnosed with a posterior reversible encephalopathy syndrome, one as having transplantation-associated thrombotic microangiopathy, and one with transient seizure caused by hypertension. Fifteen patients tested positive, of which four had single infections and eleven had mixed infections. Five cases of fungal infections, six cases of bacterial infections, and 13 cases of viral infections were detected. Among the 13 cases of viral infections, ten cases were CMV(HHV-5); three were BKPyV; two were Torque teno virus (TTV); Two were HHV-1,two were EBV(HHV4), and one each of HpyV5 and HHV-6B. Thirteen patients tested positive for virus while the qPCR detection method of 6 identical specimens were below the minimum detection limit(<1×10(3) U/ml). The mNGS technique is highly sensitive, and it can be used to diagnose CNS infections after allo-HSCT. |
format | Online Article Text |
id | pubmed-8476959 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84769592021-09-29 Metagenomic Next Generation Sequencing in the Detection of Pathogens in Cerebrospinal Fluid of Patients After Alternative Donor Transplantation: A Feasibility Analysis Zhang, Binglei Zhou, Jian Gui, Ruirui Li, Zhen Zu, Yingling Wang, Juan Yu, Fengkuan Zhang, Yanli Zhao, Huifang Ji, Zhenyu Song, Yongping Front Cell Infect Microbiol Cellular and Infection Microbiology Central nervous system (CNS) complications can occur in 9%–15% of patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The clinical manifestations of the CNS complications are non-specific, with most of them being disturbances of consciousness, convulsions, headaches, fever, and epilepsy, making it difficult to infer the cause of the complications based on clinical manifestations. We retrospectively analyzed the sensitivity and feasibility of metagenomic next generation sequencing (mNGS) in the diagnosis of CNS infections after allo-HSCT. Lumbar punctures were performed on 20 patients with CNS symptoms after receiving alternative donor HSCT(AD-HSCT) at the Affiliated Cancer Hospital of Zhengzhou University from February 2019 to December 2020, and their cerebrospinal fluid (CSF) was collected. The mNGS technique was used to detect pathogens in the CSF. Routine CSF testing, biochemical analyses, G experiments, GM experiments, ink staining, acid-fast staining, and bacterial cultures were carried out, and quantitative PCR (qPCR) tests were used to detect cytomegalovirus (CMV), Epstein-Barr virus (EBV), BK polyomavirus (BKPyV), and human alphaherpesvirus (HHV). A total of 29 tests were performed with 21 of them being positive. Of the five negative patients, three were diagnosed with a posterior reversible encephalopathy syndrome, one as having transplantation-associated thrombotic microangiopathy, and one with transient seizure caused by hypertension. Fifteen patients tested positive, of which four had single infections and eleven had mixed infections. Five cases of fungal infections, six cases of bacterial infections, and 13 cases of viral infections were detected. Among the 13 cases of viral infections, ten cases were CMV(HHV-5); three were BKPyV; two were Torque teno virus (TTV); Two were HHV-1,two were EBV(HHV4), and one each of HpyV5 and HHV-6B. Thirteen patients tested positive for virus while the qPCR detection method of 6 identical specimens were below the minimum detection limit(<1×10(3) U/ml). The mNGS technique is highly sensitive, and it can be used to diagnose CNS infections after allo-HSCT. Frontiers Media S.A. 2021-09-14 /pmc/articles/PMC8476959/ /pubmed/34595132 http://dx.doi.org/10.3389/fcimb.2021.720132 Text en Copyright © 2021 Zhang, Zhou, Gui, Li, Zu, Wang, Yu, Zhang, Zhao, Ji and Song https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Zhang, Binglei Zhou, Jian Gui, Ruirui Li, Zhen Zu, Yingling Wang, Juan Yu, Fengkuan Zhang, Yanli Zhao, Huifang Ji, Zhenyu Song, Yongping Metagenomic Next Generation Sequencing in the Detection of Pathogens in Cerebrospinal Fluid of Patients After Alternative Donor Transplantation: A Feasibility Analysis |
title | Metagenomic Next Generation Sequencing in the Detection of Pathogens in Cerebrospinal Fluid of Patients After Alternative Donor Transplantation: A Feasibility Analysis |
title_full | Metagenomic Next Generation Sequencing in the Detection of Pathogens in Cerebrospinal Fluid of Patients After Alternative Donor Transplantation: A Feasibility Analysis |
title_fullStr | Metagenomic Next Generation Sequencing in the Detection of Pathogens in Cerebrospinal Fluid of Patients After Alternative Donor Transplantation: A Feasibility Analysis |
title_full_unstemmed | Metagenomic Next Generation Sequencing in the Detection of Pathogens in Cerebrospinal Fluid of Patients After Alternative Donor Transplantation: A Feasibility Analysis |
title_short | Metagenomic Next Generation Sequencing in the Detection of Pathogens in Cerebrospinal Fluid of Patients After Alternative Donor Transplantation: A Feasibility Analysis |
title_sort | metagenomic next generation sequencing in the detection of pathogens in cerebrospinal fluid of patients after alternative donor transplantation: a feasibility analysis |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476959/ https://www.ncbi.nlm.nih.gov/pubmed/34595132 http://dx.doi.org/10.3389/fcimb.2021.720132 |
work_keys_str_mv | AT zhangbinglei metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis AT zhoujian metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis AT guiruirui metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis AT lizhen metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis AT zuyingling metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis AT wangjuan metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis AT yufengkuan metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis AT zhangyanli metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis AT zhaohuifang metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis AT jizhenyu metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis AT songyongping metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis |